Frequently, buying stocks trading below their fundamental net worth can yield lucrative rewards for investors.
News & Analysis: Mallinckrodt
Indiscriminate sell-offs can lead to opportunities the crowds have missed. Here are three stocks that fit the criteria.
MNK earnings call for the period ending March 31, 2020.
Investors were disappointed by the company's Q1 results and the prospects of continued challenges from the COVID-19 pandemic.
A small-cap pharmaceuticals company may hold the solution to a nearly 100,000% drug price hike.
MNK earnings call for the period ending December 31, 2019.
The $1.6 billion deal would release the pharmaceutical company from all opioid-related claims.
The drugmaker topped Wall Street's estimates for both the top and bottom lines. And it had some other big news that overshadowed its Q4 performance.
Investors are cheering the company's deal to settle opioid-related lawsuits.
Shares fell by as much as 45% in light of the news.